163 related articles for article (PubMed ID: 24951465)
1. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.
Ondrejka SL; Jegalian AG; Kim AS; Chabot-Richards DS; Giltnane J; Czuchlewski DR; Shetty S; Sekeres MA; Yenamandra A; Head D; Jagasia M; Hsi ED
Haematologica; 2014 Sep; 99(9):e148-51. PubMed ID: 24951465
[No Abstract] [Full Text] [Related]
2. Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.
Chang H; Chuang WY; Sun CF; Barnard MR
Diagn Pathol; 2012 Feb; 7():19. PubMed ID: 22356850
[TBL] [Abstract][Full Text] [Related]
3. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.
Horiuchi M; Yoshida M; Yamasaki K; Sakagami R; Aoyama T; Tatsumi N; Tsutsumi M; Nakaya Y; Fuseya H; Yoshimura T; Hayashi Y; Nakao T; Yamane T
Ann Hematol; 2021 May; 100(5):1329-1331. PubMed ID: 33150465
[No Abstract] [Full Text] [Related]
5. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
6. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.
Kobayashi K; Mitsui K; Ichikawa H; Nakabayashi K; Matsuoka M; Kojima Y; Takahashi H; Iijima K; Ootsubo K; Oboki K; Okita H; Yasuda K; Sakamoto H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Ohara A
Br J Haematol; 2014 Jun; 165(6):836-41. PubMed ID: 24628626
[TBL] [Abstract][Full Text] [Related]
7. Novel constitutional translocations t(3;5)(p25;q22) and t(1;14)(p31;q21) in patients with acute leukemia.
Panani AD; Pappa V; Raptis SA
Ann Hematol; 2004 Mar; 83(3):156-9. PubMed ID: 15064864
[TBL] [Abstract][Full Text] [Related]
8. Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier.
Blütters-Sawatzki R; Borkhardt A; Grathwohl J; Repp R; Rheinisch-Becker I; Bohle RM; Lampert F
Ann Hematol; 1995 Jan; 70(1):31-5. PubMed ID: 7827204
[TBL] [Abstract][Full Text] [Related]
9. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
10. Myeloid and lymphoid neoplasms with FGFR1 abnormalities: diagnostic and therapeutic challenges.
Savage NM; Johnson RC; Gotlib J; George TI
Am J Hematol; 2013 May; 88(5):427-30. PubMed ID: 22886804
[No Abstract] [Full Text] [Related]
11. Sudan black B positivity in acute lymphoblastic leukemia.
Ngan M; Chien K; Lee S
Mod Pathol; 1992 Jan; 5(1):68-70. PubMed ID: 1542637
[TBL] [Abstract][Full Text] [Related]
12. [Childhood myeloid neoplasms with PDGFRβ rearrangement progressed to acute lymphoblastic leukemia: a case report and review of the literature].
Bai L; Cheng YF; Wang B
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):871-3. PubMed ID: 22339966
[No Abstract] [Full Text] [Related]
13. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
14. Pathologic diagnosis of acute lymphocytic leukemia.
Lai R; Hirsch-Ginsberg CF; Bueso-Ramos C
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1209-35. PubMed ID: 11147220
[TBL] [Abstract][Full Text] [Related]
15. T-cell lymphoblastic lymphoma with blood eosinophilia and associated myeloid malignancy.
Tassies D; Cervantes F; Feliu E; Ordi J; Campo E; Rozman C
Am J Surg Pathol; 1993 Jan; 17(1):92-3. PubMed ID: 8447514
[No Abstract] [Full Text] [Related]
16. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
[TBL] [Abstract][Full Text] [Related]
17. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Inhorn RC; Aster JC; Roach SA; Slapak CA; Soiffer R; Tantravahi R; Stone RM
Blood; 1995 Apr; 85(7):1881-7. PubMed ID: 7661940
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
19. t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
Sheng G; Zeng Z; Pan J; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Acta Haematol; 2017; 137(1):40-43. PubMed ID: 27894117
[No Abstract] [Full Text] [Related]
20. Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report.
Ysebaert L; Carli PM; Casasnovas RO; Girodon F; Caillot D; Mugneret F; Maynadié M
Leukemia; 2001 Oct; 15(10):1673-4. PubMed ID: 11587233
[No Abstract] [Full Text] [Related]
[Next] [New Search]